Literature DB >> 7685805

Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Y M Graus1, M H De Baets.   

Abstract

Myasthenia gravis (MG) is an organ-specific autoimmune disease caused by an antibody-mediated assault on the muscle nicotinic acetylcholine receptor (AChR) at the neuromuscular junction. Binding of antibodies to the AChR leads to loss of functional AChRs and impairs the neuromuscular signal transmission, resulting in muscular weakness. Although a great deal of information on the immunopathological mechanisms involved in AChR destruction exists due to well-characterized animal models, it is not known which etiological factors determine the susceptibility for the disease. This review gives an overview of the literature on the AChR, MG and experimental models for this autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685805     DOI: 10.1007/bf02918370

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  255 in total

1.  Serum factor blocks neuromuscular transmission in myasthenia gravis: electrophysiologic study with intracellular microelectrodes.

Authors:  N Shibuya; K Mori; Y Nakazawa
Journal:  Neurology       Date:  1978-08       Impact factor: 9.910

2.  Histometric study of neuromuscular junction ultrastructure. I. Myasthenia gravis.

Authors:  T Santa; A G Engel; E H Lambert
Journal:  Neurology       Date:  1972-01       Impact factor: 9.910

3.  Microenvironments in the normal thymus and the thymus in myasthenia gravis.

Authors:  M Bofill; G Janossy; N Willcox; M Chilosi; L K Trejdosiewicz; J Newsom-Davis
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

4.  Monoclonal antibodies as probes of acetylcholine receptor structure. 2. Binding to native receptor.

Authors:  B Conti-Tronconi; S Tzartos; J Lindstrom
Journal:  Biochemistry       Date:  1981-04-14       Impact factor: 3.162

5.  C5 gene influences the development of murine myasthenia gravis.

Authors:  P Christadoss
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

6.  Attempts to implicate viruses in myasthenia gravis.

Authors:  T Aoki; D B Drachman; D M Asher; C J Gibbs; S Bahmanyar; J S Wolinsky
Journal:  Neurology       Date:  1985-02       Impact factor: 9.910

7.  Monoclonal antibodies specific for each of the two toxin-binding sites of Torpedo acetylcholine receptor.

Authors:  A J Dowding; Z W Hall
Journal:  Biochemistry       Date:  1987-10-06       Impact factor: 3.162

8.  Three-dimensional structure of the acetylcholine receptor by cryoelectron microscopy and helical image reconstruction.

Authors:  C Toyoshima; N Unwin
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

9.  Linkage between the frequency of muscular weakness and loci that regulate immune responsiveness in murine experimental myasthenia gravis.

Authors:  P W Berman; J Patrick
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

10.  Experimental myasthenia gravis. A murine system.

Authors:  P W Berman; J Patrick
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

View more
  8 in total

1.  An extended pharmacokinetic/pharmacodynamic model describing quantitatively the influence of plasma protein binding, tissue binding, and receptor binding on the potency and time course of action of drugs.

Authors:  J H Proost; J M Wierda; D K Meijer
Journal:  J Pharmacokinet Biopharm       Date:  1996-02

Review 2.  Thymectomy for myasthenia gravis.

Authors:  J D Urschel; R P Grewal
Journal:  Postgrad Med J       Date:  1998-03       Impact factor: 2.401

3.  Molecular biomarkers in glaucoma.

Authors:  Sanjoy K Bhattacharya; Richard K Lee; Franz H Grus
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-07       Impact factor: 4.799

4.  The repeated measurement of vital capacity is a poor predictor of the need for mechanical ventilation in myasthenia gravis.

Authors:  P Rieder; M Louis; P Jolliet; J C Chevrolet
Journal:  Intensive Care Med       Date:  1995-08       Impact factor: 17.440

Review 5.  Immunological mechanisms in glaucoma.

Authors:  F Grus; D Sun
Journal:  Semin Immunopathol       Date:  2008-03-11       Impact factor: 9.623

6.  Autoimmune hepatitis in a patient with myasthenia gravis and thymoma--a report on the first case in Korea.

Authors:  Y S Han; B H Kim; T H Kim; S H Dong; H J Kim; Y W Chang; J I Lee; Y W Kim; J C Park
Journal:  Korean J Intern Med       Date:  2000-07       Impact factor: 2.884

Review 7.  The immune system as a system of relations.

Authors:  Marc Daëron
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

8.  γ-Synuclein antibodies have neuroprotective potential on neuroretinal cells via proteins of the mitochondrial apoptosis pathway.

Authors:  Corina Wilding; Katharina Bell; Sabine Beck; Sebastian Funke; Norbert Pfeiffer; Franz H Grus
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.